These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15767877)

  • 1. Pupillographic evaluation of the time course of atropine effects in the mouse eye.
    Schaeffel F; Burkhardt E
    Optom Vis Sci; 2005 Mar; 82(3):215-20. PubMed ID: 15767877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice.
    Barathi VA; Beuerman RW; Schaeffel F
    Vision Res; 2009 Feb; 49(3):383-7. PubMed ID: 19059278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 0.05% racanisodamine on pupil size and accommodation.
    Chen Z; Li T; Yao P; Xu Y; Zhou X
    Optom Vis Sci; 2010 Dec; 87(12):966-70. PubMed ID: 20935583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects.
    Kaymak H; Fricke A; Mauritz Y; Löwinger A; Klabe K; Breyer D; Lagenbucher A; Seitz B; Schaeffel F
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2211-2217. PubMed ID: 30145612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
    Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
    Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys.
    Tigges M; Iuvone PM; Fernandes A; Sugrue MF; Mallorga PJ; Laties AM; Stone RA
    Optom Vis Sci; 1999 Jun; 76(6):397-407. PubMed ID: 10416935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasympathetic control of the pupillary light response in the red-eared slider turtle (Pseudemys scripta elegans).
    Dearworth JR; Cooper LJ; McGee C
    Vet Ophthalmol; 2007; 10(2):106-10. PubMed ID: 17324166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken.
    Mathis U; Feldkaemper M; Wang M; Schaeffel F
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):319-333. PubMed ID: 31879820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of topical administration of atropine sulfate on the normal equine pupil: influence of age, breed and gender.
    Davis JL; Stewart T; Brazik E; Gilger BC
    Vet Ophthalmol; 2003 Dec; 6(4):329-32. PubMed ID: 14641831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mydriatic effect of topical glycopyrrolate.
    Varssano D; Rothman S; Haas K; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1996 Mar; 234(3):205-7. PubMed ID: 8720721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
    Chia A; Lu QS; Tan D
    Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravitreally and intraperitoneally injected atropine on two types of experimental myopia in chicken.
    Diether S; Schaeffel F; Lambrou GN; Fritsch C; Trendelenburg AU
    Exp Eye Res; 2007 Feb; 84(2):266-74. PubMed ID: 17101130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast sensitivity of wildtype mice wearing diffusers or spectacle lenses, and the effect of atropine.
    Schmucker C; Schaeffel F
    Vision Res; 2006 Mar; 46(5):678-87. PubMed ID: 15993919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Atropine in the Control of Myopia.
    Tan D; Tay SA; Loh KL; Chia A
    Asia Pac J Ophthalmol (Phila); 2016; 5(6):424-428. PubMed ID: 27898446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Monocular Atropinization on Refractive Error and Eye Growth in Infant New World Monkeys.
    Whatham AR; Lunn D; Judge SJ
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2623-2630. PubMed ID: 31226711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acceptability and visual impact of 0.01% atropine in a Caucasian population.
    Loughman J; Flitcroft DI
    Br J Ophthalmol; 2016 Nov; 100(11):1525-1529. PubMed ID: 26903521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
    Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
    Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.